Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) ("60 Degrees" or the "Company"), a pharmaceutical company focused on developing new medicines for vector-borne disease, today announced that three ...

Breakthrough Therapy Designation request has been submitted to FDA Company to request a Type B meeting with FDA in early 2026 to discuss requirements for a supplementary New Drug Application (sNDA) ...

Signing of a Patent License Agreement with Tufts Medical Center to jointly advance the development of tafenoquine for babesiosis treatment, indicating a strategic collaboration that enhances the ...

WASHINGTON, July 09, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (SXTP) (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharmaceuticals” or the “Company”), a pharmaceutical company focused on ...

Tick-borne diseases are spreading into new parts of the United States at a pace that has caught public health officials off guard. Babesiosis, a potentially fatal parasitic infection once confined to ...

A survey suggests babesiosis cases in the U.S. may be significantly underreported, with millions experiencing chronic fatigue linked to the disease. A recent survey by 60 Degrees Pharmaceuticals, Inc.

Cases of a tick-borne parasitic disease have steadily increased in recent years, a new study shows. Rates of babesiosis increased an average 9% a year in the United States between 2015 and 2022, ...

OFFICERS TRUE HEROES. MULTIPLE CONFIRMED CASES. AND I’M GOING TO LET THE DOCTOR HERE TAKE THIS WORD. BABESIOSIS IN MASSACHUSETTS, THAT’S A DISEASE PRIMARILY SPREAD BY DEER TICKS. SO WE TALK A LOT ...

Company engaged patients diagnosed with chronic babesiosis via social media in a nationwide naming competition A $5K donation from the Company was split between ILADEF and GLA to recognize the winning ...

More Than A Third Of Blacklegged Ticks Carry Disease, And One Parasite Is Spreading In A Nutshell A nine-year New York study found more than one in three blacklegged ticks infected with at least one ...